Cervantes-Gomez et al. also evaluated the effect of SGI-1776 on myeloma cell lines and CD138(+) myeloma cells and revealed that SGI-1776 treatment led to apoptosis in both replicating primary cells and proliferating cell lines [79]. This evidence concerns the gene SDC1 and plasma cell myeloma.